ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data.

February 4, 2005

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

National TV Attack On Cancer Program Gets Response From Schmidt; Some NCAB Members Side With Kornberg

June 28, 1974

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

In Brief: Jordan, Fisher Win Brinker Awards; AFUD Forms 100th Us Too Prostate Cancer Support Group

October 30, 1992